US to start student visa application process from mid-May
Darpan News Desk IANS, 02 May, 2023 03:47 PM
New Delhi, May 2 (IANS) The US will begin processing student visa applications for the Fall Session with the first batch of appointments available from mid-May.
"Attention students! In mid-May, the US Mission to India will open the first batch of appointments for the upcoming student visa season," the US Consulate General in Hyderabad announced via a tweet.
"Additional appointments will be released later in the season. Prepare for your appointments and stay tuned for more student visa related announcements," it said.
The US consulates processed nearly 1.25 lakh visa applications of students in India last year.
The country intends to increase visa interview appointments for Indian students by 30 per cent this summer.
In a much needed breather for students, the State Department announced in February that the 'F' and 'M' categories of student visas can now be issued up to a year in advance.
Previously, international students could apply only 120 days before the start of their study program.
Now they can submit their application 365 days in advance.
The development comes with the State Department announcing a hike in the fees of student visas.
Beginning May 30, the fees for non-petition based NIVs such as student and exchange visitor visas, will increase from $160 to $185 (Rs 15,140 for Indians).
The COLA affects the personal finances of about 1 in 5 Americans, including Social Security recipients, disabled veterans and federal retirees, some 70 million people in all.
The Associated Press-NORC Center for Public Affairs Research poll finds that 17% of Americans say they are providing ongoing caregiving, part of an informal volunteer corps.
Reinfection so far has been rare. The best known example: Researchers in Hong Kong said a man had mild COVID-19 and then months later was infected again but showed no symptoms.
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.
The seven-day rolling average for new U.S. cases has climbed over the past two weeks to almost 42,000 per day. The nation also sees more than 700 COVID-19 deaths each day.
